Prevalence of clinically overt cytomegalovirus disease in kidney transplant patients.
Mancilla
E
E
Department of Transplants, Instituto Nacional de la Nutrición Salvador Zubirán, México D.F.
Alberú
J
J
Alessio-Robles
L
L
Elizondo
J
J
Reyes
E
E
Sifuentes-Osornio
J
J
Bordes-Aznar
J
J
D000212:Acyclovir / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology; D015995:Prevalence; D012189:Retrospective Studies; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000212:Acyclovir